Product Search
RESEARCH
REFSYN BIOSCIENCES is a Contract Research Organization (CRO) established in 2012, Pondicherry, which offers a wide range of research services to the Industries related to Pharmaceutical, Biotechnology and Agricultural industry and Academic like research institutions, universities, in addition to governmental organizations, in the form of research services outsourced on a contract basis. We are providing quality service, with focus on reducing time and cost, we understand the customer requirement and working close with them to match their timeline.
Our team provides synthesis of DRUG METABOLITES as Reference standard compounds at the multi scale level for the confirmation and pharmacologic/toxicological characterization as well as for academic institutions and Clinical research studies of drugs with high purity.
We are supplying APIs related compounds, Impurities, hydroxy Metabolites, Demethyl Metabolites, N-oxide metabolites which are considered as Phase-I metabolites. Also, we under take for the synthesis of Glucuronide metabolites (Phase-II metabolites).
Refsyn-drug impurities and drug metabolites CLICK HERE
Our Products
| PRODUCT CODE | COMPOUND NAME | CAS NO | SYNONYMS |
| ACECLOFENAC | |||
| RBPL-A0101 | Aceclofenac impurity A | 15307-86-5 | SYNONYMS: Diclofenac free acid |
| RBPL-A0102 | Aceclofenac impurity B | 15307-78-5 | SYNONYMS: Methyl [2-[(2,6-dichlorophenyl) amino] phenyl]acetate; Diclofenac methyl ester |
| RBPL-A0103 | Aceclofenac impurity I | 15362-40-0 | SYNONYMS: Diclofenac Amide |
| RBPL-A0104 | Aceclofenac impurity E | 139272-67-6 | SYNONYMS: 2-[(2,6-Dichlorophenyl)amino]benzeneacetic Acid 2-Ethoxy-2-oxoethyl Ester; Aceclofenac ethyl ester |
| RBPL-A0105 | Aceclofenac impurity D | 139272-66-5 | SYNONYMS: Methyl [[[2-[(2,6-dichlorophenyl)amino]phenyl] acetyl]oxy]acetate; Aceclofenac methyl ester |
| RBPL-A0106 | Aceclofenac impurity F | 100499-89-6 | SYNONYMS: Aceclofenac Benzyl Ester; 2-[(2,6-Dichlorophenyl)amino]benzeneacetic Acid 2-Oxo-2-(phenylmethoxy)ethyl Ester; |
| RBPL-A0107 | Aceclofenac impurity G | 1215709-75-3 | SYNONYMS: Acetic Aceclofenac; 2-[(2,6-Dichlorophenyl)amino]benzeneacetic Acid 2-(Carboxymethoxy)-2-oxoethyl Ester |
| AZITHROMYCIN | |||
| RBPL-A0201 | Azithromycin impurity E | 612069-27-9 | SYNONYMS: Azithromycin-N,N'-Didesmethyl; (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(3-Amino-3,4,6-trideoxy-β-D-xylo-hexopyranosyl)oxy]-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one; Aminoazithromycin A |
| RBPL-A0202 | Azithromycin impurity F | 612069-28-0 | SYNONYMS: 3’-N-Desmethyl-3’-N-formyl Azithromycin |
| RBPL-A0203 | Azithromycin impurity I | 172617-84-4 | SYNONYMS: 3′-N-Demethylazithromycin |
| RBPL-A0204 | Azithromycin impurity L | 90503-06-3 | SYNONYMS: Azithromycin 3'-N-Oxide |
| ALBENDAZOLE | |||
| RBPL-A0301 | Albendazole impurity C | 75184-71-3 | SYNONYMS: Albendazole Sulfone |
| RBPL-A0302 | Albendazole impurity B | 54029-12-8 | SYNONYMS: Albendazole Sulfoxide |
| RBPL-A0305 | Albendazole impurity A | 80983-36-4 | SYNONYMS: Amino Albendazole |
| ACEBUTALOL | |||
| RBPL-A0401 | Acebutalol impurity C | 40188-45-2 | SYNONYMS: N-(3-Acetyl-4-hydroxyphenyl)butanamide |
| RBPL-A0402 | Acebutalol impurity J | 57898-79-0 | SYNONYMS: N-[3-Acetyl-4-[(2RS)-2-hydroxy-3-[(1-methylethyl) amino] propoxy] phenyl] propanamide |
| AZELASTINE | |||
| RBPL-A0501 | Azelastine impurity A | 613-94-5 | SYNONYMS: Benzoyl hydrazine |
| ATORVASTATIN | |||
| RBPL-A0801 | Atorvastatin Impurity H | 125995-03-1 | SYNONYMS: Atorvastatin lactone; 5-(4-Fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide; Atorvastatin δ- |
| RBPL-A0804 | Atovastatin related compound D | 148146-51-4 | SYNONYMS: Atorvastatin Epoxydione; 3-(4-Fluorobenzoyl)-2-(2-methyl-1-oxopropyl)-N,3-diphenyloxirane carboxamide; |
| ASPIRIN | |||
| RBPL-A0901 | Aspirin Impurity E | 552-94-3 | SYNONYMS: Salicilyl salicylic acid; 2-Hydroxybenzoic acid 2-carboxyphenyl ester |
| RBPL-A0902 | Aspirin Impurity F | 1466-82-6 | SYNONYMS: Acetyl salicylic acid |
| AMOXICILLIN | |||
| RBPL-A1001 | Aspirin Impurity E | 551-16-6 | SYNONYMS: 6-Aminopenicillanic acid; 2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-APA ; Flucloxacillin impurity C; Amoxicillin related compound A |
| ARIPIPRAZOLE | |||
| RBPL-A1101 | Aripiprazole Related Compound F | 573691-09-5 | SYNONYMS: 7-[4-[4-(2,3-Dichlorophenyl)-1-oxido-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone; Aripiprazole-N-oxide |
| RBPL-A1102 | Aripiprazole-N,N'-dioxide | 573691-13-1 | SYNONYMS: 7-[4-[4-(2,3-Dichlorophenyl)-1,4-dioxido-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone |
| ACETAZOLAMIDE | |||
| RBPL-A1201 | Acetazolamide impurity A | 60320-32-3 | SYNONYMS: N-(5-Chloro-1,3,4-thiadiazol-2-yl)acetamide; 2-Acetamido-5-chloro-1,3,4-thiadiazole; 2-(Acetylamino)-5-chloro-1,3,4-thiadiazole; 2-Amino-5-acetamido-1,3,4-thiadiazole; NSC 231656 |
| RBPL-A1202 | Acetazolamide impurity B | NA | SYNONYMS: 2‐(Acetylamino)‐1,3,4‐Thiadiazole; N-1,3,4-thiadiazol-2-ylacetamide;[(1S,4R)-4-(2-amino-6-chloro-9H-purin-9-yl)cyclopent-2-enyl]methanol hydrochloride |
| RBPL-A1203 | Acetazolamide impurity E | 827026-60-8 (free acid) | SYNONYMS: 5-acetamido-1,3,4-thiadiazole-2-sulfonic acid |
| AMLODIPINE | |||
| RBPL-A1301 | Amlodipine impurity A | 88150-62-3 | SYNONYMS: Phthalimide amlodipine; 4-(2-Chlorophenyl)-2-[[2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)ethoxy]methyl]-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic Acid 3-Ethyl 5-Methyl Ester; 4-(2-Chlorophenyl)-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-2-[(2-phthalimidoethoxy)methyl]-1,4-dihydropyridine; Phthaloyl Amlodipine |
| BECLOMETHASONE | |||
| RBPL-B0101 | Beclomethasone Impurity R | NA | SYNONYMS: --- |
| RBPL-B0102 | Beclomethasone Impurity G | 1186048-33-8 | SYNONYMS: Betamethasone Tripropionate; Betamethasone 11,17,21-Tripropionate, (11β,16β)-9-Fluoro-16-methyl-11,17,21-tris(1-oxopropoxy)pregna-1,4-diene-3,20-dione; Betamethasone 11,17,21-Tripropionate |
| RBPL-B0103 | Beclomethasone Impurity V | 205105-83-5 | SYNONYMS: 9,11-epoxide-21-propionate; (9β,11β,16β)-9,11-Epoxy-17-hydroxy-16-methyl-21-(1-oxopropoxy)pregna-1,4-diene-3,20-dione; Beclomethasone 9,11-Epoxide 21-Propionate |
| BETAXOLOL | |||
| RBPL-B0201 | Betaxolo HCl impurity A (HCl) | 464877-45-0 | SYNONYMS: Des[4-(2-cyclopropylmethoxy)] Betaxolol Hydrochloride; (2RS)-1-(4-Ethylphenoxy)-3-[(1-methylethyl)amino]-2-propanol Hydrochloride; |
| BUPROPION | |||
| RBPL-B0301 | Bupropion-2-amino impurity | 119802-69-6 | SYNONYMS: 2-amino-1(3-chlorophenyl)-1-propanone; 3-Chloro Cathinone |
| RBPL-B0301 | Bupropion-2-amino impurity | 119802-69-6 | SYNONYMS: 2-amino-1(3-chlorophenyl)-1-propanone; 3-Chloro Cathinone |
| CLARITHROMYCIN | |||
| RBPL-C0101 | 14-hydroxy Clarithromycin | 116836-41-0 | SYNONYMS: --- |
| RBPL-C0102 | Clarithromycin impurity D | 101666-68-6 | SYNONYMS: N-Desmethyl Clarithromycin |
| RBPL-C0103 | Clarithromycin impurity Q | 118074-07-0 | SYNONYMS: Clarithromycin N-Oxide |
| RBPL-C0104 | Clarithromycin impurity I | 118058-74-5 | SYNONYMS: De(cladinosyl) Clarithromycin |
| RBPL-C0105 | Clarithromycin impurity K | 127157-35-1 | SYNONYMS: 3-O-De(cladinosyl)-8,9,10,11-tetradehydro-9-deoxo-11,12-dideoxy-9,12-epoxy Clarithromycin |
| RBPL-C0106 | Clarithromycin impurity L | 127253-05-8 | SYNONYMS: Clarithromycin (9Z)-Oxime |
| RBPL-C0107 | Clarithromycin impurity M | 127182-43-8 | SYNONYMS: N-Desmethyl-6-O-methylerythromycin (9E)-Oxime |
| RBPL-C0108 | Clarithromycin impurity N | 144604-03-5 | SYNONYMS: (10E)-10,11-Didehydro-11-deoxy-6-O-methylerythromycin |
| RBPL-C0109 | Clarithromycin impurity C | 103450-87-9 | SYNONYMS: Clarithromycin 9-Oxime; 6-O-Methylerythromycin 9-Oxime; 6-O-Methylerythromycin A 9-Oxime |
| CAPACITABINE | |||
| RBPL-C0201 | `Capacitabine related compound C | 921769-65-5 | SYNONYMS: Capecitabine-2',3'-cyclic Carbonate |
| CITALOPRAM | |||
| RBPL-C0301 | Citalopram impurity D | 1188264-72-3 | SYNONYMS: N-desmethyl Citalopram Hydrochloride |
| RBPL-C0304 | Citalopram impurity E | NA | SYNONYMS: Citalopram 5-Chloro Analog HBr |
| CLOPIDOGREL | |||
| RBPL-C0401 | Clopidogrel impurity A | 144750-42-5 | SYNONYMS: (S)-Clopidogrel Acid Hydrochloride; (S)-α-(2-Chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic Acid Hydrochloride; SR 26334 Hydrochloride |
| COLCHICINE | |||
| RBPL-C0501 | Colchicine impurity E | 7336-33-6 | SYNONYMS: 3-Demethyl Colchicine; N-[(7S)-5,6,7,9-Tetrahydro-3-hydroxy-1,2,10-trimethoxy-9-oxobenzo[a]heptalen-7-yl]-acetamide; O3-Demethylcolchicine; 3-Demethyl-(-)-colchicine; O3-Demethylcolchicine |
| CLOPIDOGREL | |||
| RBPL-C0401 | Clopidogrel impurity A | 144750-42-5 | SYNONYMS: (S)-Clopidogrel Acid Hydrochloride; (S)-α-(2-Chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic Acid Hydrochloride; SR 26334 Hydrochloride |
| COLCHICINE | |||
| RBPL-C0501 | Colchicine EP impurity E | 7336-33-6 | SYNONYMS: 3-Demethyl Colchicine; N-[(7S)-5,6,7,9-Tetrahydro-3-hydroxy-1,2,10-trimethoxy-9-oxobenzo[a]heptalen-7-yl]-acetamide; O3-Demethylcolchicine; 3-Demethyl-(-)-colchicine; O3-Demethylcolchicine |
| CLINDAMYCIN | |||
| RBPL-C0601 | Clindamycin sulphone | 887402-22-4 | SYNONYMS: -- |
| RBPL-C0602 | Clindamycin sulphoxide | 22431-46-5 | SYNONYMS: Clindamycin sulphoxide |
| CLOMPIRAMINE | |||
| RBPL-C0701 | Clompriramine impurity G | 1425793-87-8 | SYNONYMS: N-Allyl-3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine; 3-Chloro-10,11-dihydro-5-(2-propen-1-yl)-5H-dibenz[b,f]azepine |
| CLOZAPINE | |||
| RBPL-C0801 | Clozapine impurity D | 65514-71-8 | SYNONYMS: 1-[2-[(2-Amino-4-chlorophenyl) amino]benzoyl]-4-methylpiperazine; [2-[(2-Amino-4-chlorophenyl)amino]phenyl](4-methyl-1-piperazinyl)methanone, 1-[2-[(2-Amino-4-chlorophenyl)amino]benzoyl]-4-methylpiperazine |
| RBPL-C0802 | Clompriramine impurity G | 34233-69-7 | SYNONYMS: 8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine; N-oxide in-4-ium-1-yl)-5H-benzo[b][1,4]benzodiazepine hyl-1-piperazinyl)-5H-dibenzo[b,e](1,4)diazepine; N-oxide-8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine N-Oxide 3-Chloro-10,11-dihydro-5-(2-propen-1-yl)-5H-dibenz[b,f]azepine |
| CARVEDILOL | |||
| RBPL-C1001 | Carvedilol impurty A | 1076199-79-5 | SYNONYMS: 1-[[4-(2-Hydroxy-3-[[2-(methoxyphenoxy)ethyl]amino]propyl]-9H-carbazol-4-yl]oxy]-3-[[2-(2-methoxyphenoxy)ethyl]amino]propan-2-ol; 1-(9H-Carbazol-4-yloxy)-3-[[2-hydroxy-3-[[2-(2-methoxyphenoxy)ethyl]amino]propyl][2-(2-methoxyphenoxy)ethyl]amino]-2-propanol; Carvedilol Related Compound A |
| CETRIZINE | |||
| RBPL-C1101 | Cetrizine-N-oxide | 1076199-80-8 | SYNONYMS: [2-[4-(4-Chlorophenyl)phenylmethyl]-1-oxido-1-piperazinyl]ethoxy]acetic Acid |
| CLOTRIMAZOLE | |||
| RBPL-C1101 | Clotrimazole impurity E | 5162-03-8 c | SYNONYMS: (2-Chlorophenyl)(phenyl)methanone; 2-Benzoylphenyl Chloride; 2-CBP; 2-Chlorophenyl Phenyl Ketone; NSC 62529; o-Chlorobenzophenone |
| DICLOFENAC | |||
| RBPL-D0101 | Diclofenac impurity A | 15362-40-0 | SYNONYMS: Diclofenac Amide |
| RBPL-D0102 | Diclofenac isopropyl impurity | 66370-79-4 | SYNONYMS: Isopropyl 2-(2-((2,6-Dichlorophenyl)amino)phenyl)acetate |
| RBPL-D0103 | Diclofenac methyl ester impurity | 15307-78-5 | SYNONYMS: 2-[(2,6-Dichlorophenyl)amino]benzeneacetic Acid Methyl Ester; |
| RBPL-D0104 | Diclofenac impurity F | 560075-65-2 | SYNONYMS: 2,6-Dichloro-N-(4-chlorophenyl)-benzeneacetamide |
| DOMPERIDONE | |||
| RBPL-D0201 | Domperidone impurity A | 53786-28-0 | SYNONYMS: 5-Chloro-1-(4-piperidyl)-2-benzimidazolinone; Des[3-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)propyl] Domperidone; 4-(6-Chloro-1,2-dihydro-2-oxobenzo[d]imidazol-3-yl)piperidine; 5-Chloro-1-(4-piperidinyl)-1,3-dihydro-2H-benzimidazol-2-one; 5-Chloro-1-(piperidin-4-yl)-1H-benzimidazol-2(3H)-one; 5-Chloro-1-piperidin-4-yl-1,3-dihydrobenzimidazol-2-one; R 29676 |
| RBPL-D0202 | Domperidone impurity B | 1346598-11-5 | SYNONYMS: 4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)-1-formylpiperidine; 4-(6-Chloro-1,2-dihydro-2-oxobenzo[d]imidazol-3-yl)piperidine-1-carbaldehyde; 5-Chloro-1-(4-formylpiperidinyl)-1,3-dihydro-2H-benzimidazol-2-one; 5-Chloro-1-(4-formylpiperidinyl)-1H-benzimidazol-2(3H)-one; |
| DESVENLAFAXINE | |||
| RBPL-D0301 | Desvenlafaxine-N-oxide | NA | SYNONYMS: 4-[2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol N-oxide |
| FAMOTIDINE | |||
| RBPL-F0101 | Famotidine impurity B | 109467-08-5 (Dimaleate) ; 89268-62-2 | SYNONYMS: 3,5-Bis[2-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulfanyl]ethyl]-4H-1,2,4,6-thiatriazine 1,1-Dioxide Dimaleate; [[[2-[(Diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]ethyl]-4H-1,2,4,6-thiatriazine 1,1-dioxide; Famotidine Related Compound B |
| RBPL-F0102 | Famotidine impurity E | 129083-44-9 | SYNONYMS: Bis[(2-guanidino-4-thiazolyl)methyl]disulfide |
| FAMOTIDINE | |||
| RBPL-F0101 | Famotidine impurity B | 109467-08-5 (Dimaleate) ; 89268-62-2 | SYNONYMS: 3,5-Bis[2-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulfanyl]ethyl]-4H-1,2,4,6-thiatriazine 1,1-Dioxide Dimaleate; [[[2-[(Diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]ethyl]-4H-1,2,4,6-thiatriazine 1,1-dioxide; Famotidine Related Compound B |
| RBPL-F0102 | Famotidine impurity E | 129083-44-9 | SYNONYMS: Bis[(2-guanidino-4-thiazolyl)methyl]disulfide |
| FOSINOPRIL | |||
| RBPL-F0201 | Fosinoprilat | 95399-71-6 | SYNONYMS: (4S)-4-Cyclohexyl-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-L-proline; trans-4-Cyclohexyl-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-L-proline; Fosfenopril; Fosinoprilic Acid; SQ 27519; |
| FINOFIBRATE | |||
| RBPL-F0401 | Finofibrate impurity A | 42019-78-3 | SYNONYMS: 4-Chloro-4′-hydroxybenzophenone; (4-Chlorophenyl)(4-hydroxyphenyl)methanone; 4-(4-chlorobenzoyl)phenol; USP Fenofibrate Related Compound A; |
| RBPL-F0402 | Finofibrate impurity B | 42017-89-0 | SYNONYMS: Fenofibric Acid; 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methyl-propanoic Acid; FNF Acid; NSC 281318; Procetofenic Acid; |
| RBPL-F0403 | Finofibrate impurity G | 217636-48-1 | SYNONYMS: Fenofibric Acid 1,1-Dimethyl-2-(1-methylethoxy)-2-oxoethyl Ester; 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic Acid 1,1-Dimethyl-2-(1-methylethoxy)-2-oxoethyl Ester; Fenofibrate Impurity G; USP Fenofibrate Related Compound C |
| RBPL-F0404 | Finofibrate impurity C | 217636-47-0 | SYNONYMS: 3-[4-(4-Chlorobenzoyl)phenoxy]-2-butanone |
| RBPL-F0405 | Finofibrate impurity F | 154356-96-4 | SYNONYMS: (4-Chlorophenyl)[4-(1-methylethoxy)phenyl]methanone; 3-[4-(4-Chlorobenzoyl)phenoxy]-2-propane; |
| FINASTERIDE | |||
| RBPL-F0501 | Finasteride impurity A | 98319-24-5 | SYNONYMS: 1,2-dihydro finasteride; Dihydro Finasteride; Dihydroproscar; (5α,17β)-N-(1,1-Dimethylethyl)-3-oxo-4-azaandrostane-17-carboxamide; [4aR-(4aα,4bβ,6aα,7α,9aβ,9bα, 11aβ)]- N-(1,1-Dimethylethyl)hexadecahydro-4a,6a-dimethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxamide; 1,2-Dihydrofinasteride; 3-Oxo-4-aza-5α-androstan-17β-carboxylic acid N-(tert-butyl)amide; N-(tert-Butyl)-3-oxo-4-aza-5α-androstane-17β-carboxamide; |
| RBPL-F0502 | Finasteride impurity B | 103335-41-7 | SYNONYMS: 3-Oxo-4-aza-5α-αndrost-1-ene-17β-carboxylic Acid Methyl Ester; (4aR,4bS,6aS,7S,9aS,9bS,11aR)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-Tetradecahydro-4a,6a-dimethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxylic Acid Methyl Ester; (5α,17β)-3-Oxo-4-azaandrost-1-ene-17-carboxylic Acid Methyl Ester; Methyl 3-Oxo-4-aza-5α-androst-1-ene-17β-carboxylate; Finasteride Impurity; |
| GALANTHAMINE | |||
| RBPL-G0101 | Galanthamine impurity B | 1668-85-5 | SYNONYMS: Epi Galanthamine |
| RBPL-G0102 | Galanthamine impurity D | 664995-65-7 | SYNONYMS: Anhydro Galanthamine |
| GABAPENTINE | |||
| RBPL-G0201 | Gabapentine impurity A | 64744-50-9 | SYNONYMS: Gabapentine lactam; 3-Azaspiro-[4,5]decan-3-one; Gabapentin Lactam; Gabapentin Related Compound A |
| IMATINIB | |||
| RBPL-I0101 | Imatinib impurity E | 1365802-18-1 | SYNONYMS: Imatinib dimer; Des(methylpiperazinyl-N-methyl) Imatinib Dimer Impurity; 1,4-Bis-[4-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]carbamoyl]benzylpiperazine |
| IBUPROFEN | |||
| RBPL-I0201 | Ibuprofen impurity L | 53949-53-4 | SYNONYMS: 1-Hydroxy Ibuprofen (Ibuprofen Impurity L) (Mixture of Diastereomers), 4-(1-Hydroxy-2-methylpropyl)-α-methylbenzeneacetic Acid; 2-[4-(1-Hydroxy-2-methylpropyl)phenyl] propionic Acid; |
| RBPL-I0202 | Ibuprofen impurity E | 38861-78-8 | SYNONYMS: 1-(4-Isobutylphenyl) ethanone; 1-[4-(2-Methylpropyl)phenyl] ethanone; 1-Acetyl-4-isobutylbenzene; 1-[4-(2-Methylpropyl)phenyl]-1-ethanone; 1-[4-(2-Methylpropyl)phenyl]ethanone; 4-(2-Methylpropyl)acetophenone; NSC 173015; p-Acetylisobutyl benzene; p-Isobutylacetophenone; p-Isobutylphenyl Methyl Ketone; 4-IBAP; Ibuprofen Related Compound C; |
| ITRACONAZOLE | |||
| RBPL-I0301 | Itraconazole impurity C | 74855-91-7 | SYNONYMS: Propyl Itraconazole; cis-4-[4-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-propyl-3H-1,2,4-triazol-3-one; |
| KETORALAC | |||
| RBPL-K0101 | Ketoralac impurity D | 1391053-45-4 | SYNONYMS: 1-Methoxy Ketorolac ; Ketorolac 1-Methoxy Impurity ; (1RS)-5-Benzoyl-1-methoxy-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid sodium salt |
| LIFLUNOMIDE | |||
| RBPL-L0201 | Liflunomide impurity E | 208401-20-1 | SYNONYMS: 5-Desmethyl-3-methyl Leflunomide; 3-Methyl-N-[4-(trifluoromethyl)phenyl]-4-isoxazolecarboxamide; N-[4-(Trifluoromethyl)phenyl]-3-methylisoxazole-4-carboxamide |
| LAMOTRIGINE | |||
| RBPL-L0301 | Lamotrigine impurity F | 252186-79-1 | SYNONYMS: 3-(2,3-Dichlorobenzamido) Lamotrigine; N-[5-Amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl]-2,3-dichlorobenzamide; Lamotrigine related compound D |
| LANSOPRAZOLE | |||
| RBPL-L0402 | Lansoprazole sulphone N-oxide | 953787-54-7 | SYNONYMS: 2-[[[3-Methyl-1-oxido-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole |
| RBPL-L0403 | Lansoprazole impurity C | 103577-40-8 | SYNONYMS: Lansoprazole sulphide; 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]thio]-1H-benzimidazole; AG 1777; H 225/18; K 1252 |
| LOPERAMIDE | |||
| RBPL-L0601 | Loperamide impurity B | NA | SYNONYMS: 4-(4-chlorophenyl)-1,1-bis[4-(dimethylamino)-4-oxo-3,3-diphenylbutyl]-4-hydroxypiperidinium |
| RBPL-L0602 | Loperamide impurity G | 106900-12-3 | SYNONYMS: trans-4-(4-Chlorophenyl)-4-hydroxy-N,N-dimethyl-α,α-diphenyl-1-piperidinebutanamide 1-Oxide; Arestal; Loperamide Oxide; R 58425 |
| MELOXICAM | |||
| RBPL-M0101 | Meloxicam impurity B | 7305-71-7 | SYNONYMS: 2-Amino-5-methylthiazole |
| METOPROLOL | |||
| RBPL-M0201 | Metoprolol epoxide | 56718-70-8 | SYNONYMS: 1-[2-(2-methoxyethyl)phenyoxy]-2,3-epoxypropane; Metoprolol impurity stage-IA ; 2-[[4-(2-Methoxyethyl)phenoxy]methyl-oxirane; [[4-(2-Methoxyethyl)phenoxy] methyl]-oxirane; MEEPB; Metoprolol Impurity VII |
| RBPL-M0202 | Metoprolol impurity H | 62572-94-5 | SYNONYMS: O-Desmethyl Metoprolol; 4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]-benzeneethanol;(+/-)-4-[2-Hydroxy-3-(isopropylamino)propoxy]phenylethyl Alcohol; (+/-)-O-Demethylmetoprolol; H 105/22; SL 80-0088; |
| RBPL-M0203 | Metoprolol impurity B | 56718-71-9 | SYNONYMS: Metoprolol Impurity I; p-(2-Methoxyethyl)phenol; 4-(2-Methoxyethyl)phenol |
| RBPL-M0204 | Metoprolol impurity G | 501-94-0 | SYNONYMS: Tyrosol; 4-Hydroxy-benzeneethanol; 2-(4-Hydroxyphenyl)ethanol; 2-(4-Hydroxyphenyl)ethyl Alcohol; NSC 59876; |
| RBPL-M0205 | Metoprolol impurity M | 73313-36-7 | SYNONYMS: 1,3-Bis[(1-methylethyl)amino]-2-propanol Dihydrochloride; |
| RBPL-M0206 | Metoprolol impurity N | 6452-57-9 | SYNONYMS: 3-Isopropylamino-1,2-propanediol; 3-[(1-Methylethyl)amino]-1,2-propanediol; 1,2-Dihydroxy-3-isopropylaminopropane; |
| MEFENAMIC ACID | |||
| RBPL-M0401 | Mefenamic acid impurity C | 118-91-2 | SYNONYMS: 2-Chlorobenzoic acid; o-Chlorobenzoic Acid; 2-CBA; NSC 15042; NSC 32737; o-Chlorobenzoic Acid; |
| METOCLOPRAMIDE | |||
| RBPL-M0301 | Metoclopramide impurity H | 50-86-2 | SYNONYMS: N-Acetyl-4-aminosalicylic Acid; 4-Acetylamino-2-hydroxybenzoic Acid; 4-Acetamidosalicylic Acid; p-Acetamidosalicylic Acid; NSC 54182 |
| METOCLOPRAMIDE | |||
| RBPL-M0301 | Metoclopramide impurity H | 50-86-2 | SYNONYMS: N-Acetyl-4-aminosalicylic Acid; 4-Acetylamino-2-hydroxybenzoic Acid; 4-Acetamidosalicylic Acid; p-Acetamidosalicylic Acid; NSC 54182 |
| MEFENAMIC ACID | |||
| RBPL-M0401 | Mefenamic acid impurity C | 118-91-2 | SYNONYMS: 2-Chlorobenzoic acid; o-Chlorobenzoic Acid; 2-CBA; NSC 15042; NSC 32737; o-Chlorobenzoic Acid; |
| RBPL-M0402 | Mefenamic acid impurity D | 65-85-0 | SYNONYMS: Benzoic acid; Benzenecarboxylic Acid; Benzeneformic Acid; Benzenemethanoic Acid; Carboxybenzene; Dracylic Acid; E 210; HA 1; MENNO-Florades; NSC 149; Phenylcarboxylic Acid; Phenylformic Acid; Purox B; Retarder BA; Retardex; Salvo Liquid; Solvo Powder; Tenn-Plas; VevoVitall; |
| MYCOPHENOLATE | |||
| RBPL-M0501 | Mycohenolate impurity F | 24280-93-1 | SYNONYMS: Mycophenolic Acid; (4E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic Acid; |
| MONTELUKAST | |||
| RBPL-M0601 | Montelukast sulfoxide | 909849-96-3 | SYNONYMS: 1-[[[1-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfinyl]methyl]cyclopropaneacetic Acid; Montelukast M2 |
| NIMSULIDE | |||
| RBPL-N0101 | Nimsulide impurity D | 5422-92-4 | SYNONYMS: 4-nitro-2-phenoxyaniline; 4-Nitro-2-phenoxybenzenamine; 2-Amino-5-nitrodiphenyl Ether; 2-Phenoxy-4-nitroaniline; NSC 10867 |
| NORADRENALIN | |||
| RBPL-N0201 | Noradrenalin impurity E | 99-40-1 | SYNONYMS: Chloro Acetyl Catechol; 2-Chloro-3,4-dihydroxyacetophenone; 1-Chloroacetyl-3,4-dihydroxybenzene; 2-Chloro-1-(3,4-dihydroxyphenyl)-1-ethanone; 3,4-Dihydroxyphenacyl chloride; Chloro Acetyl Catechol |
| RBPL-N0202 | Noradrenalin impurity F | 20455-68-9 | SYNONYMS: N-benzyl-1-phenylmethanamine; dibenzylammoniumchloride;n-(phenylmethyl)-benzenemethanaminhydrochloride;DIBENZYLAMINE HCL;DIBENZYLAMINE HYDROCHLORIDE |
| OLANZAPINE | |||
| RBPL-O0101 | Olanzapine impurity D | 174794-02-6 | SYNONYMS: Olanzapine Related CoMpound C;Olanzapine N-oxide ;2-Methyl-4-(4-methyl-4-oxido-1-piperazinyl)-10H-thieno[2,3-β][1,5]benzodiazepine;2-Methyl-4-(4-methyl-4-oxido-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine;2-Methyl-4-(4-Methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine 4'-N-oxide; |
| OMEPRAZOLE | |||
| RBPL-O0201 | Omeprazole impurity B | 37052-78-1 | SYNONYMS: 5-Methoxy-2-mercaptobenzimidazole; omeprazole imp A; 1,3-Dihydro-5-methoxy-2H-benzimidazole-2-thione; 2-Mercapto-5-methoxy-1H-benzimidazole; 2-Mercapto-5-methoxybenzimidazole; 5-Methoxy-1H-benzimidazole-2-thiol; 5-Methoxy-2-benzimidazolethiol; |
| RBPL-O0202 | Omeprazole impurity C | 73590-85-9 | SYNONYMS: Omeprazole Sulfide; Ufiprazole; 6-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]thio]-1H-benzimidazole; 2-[[(3,5-Dimethyl-4-methoxy-2-pyridyl)methyl]thio]-5-methoxybenzimidazole; Pyrmetazole |
| RBPL-O0203 | Omeprazole impurity F&G |
125656-82-8+ 125656-83-9 |
SYNONYMS: 8(9)-Methoxy-1,3-dimethyl-12-thioxopyrido[1’,2’:3,4]imidazo[1,2-a]benzimidazol-2-(12H)-one; (Mixture of Regioisomers) |
| RBPL-O0204 | Omeprazole impurity H | 863029-89-4 | SYNONYMS: 4-Desmethoxy-4-chloro Omeprazole |
| RBPL-O0205 | Omeprazole impurity I | 158812-85-2 | SYNONYMS: Omeprazole Sulfone N-Oxide; 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-1-oxido-2-pyridinyl)methyl]sulfonyl]- 1H-benzimidazole; Esomeprazole Impurity Impurity I |
| RBPL-O0206 | 4-Hydroxy omeprazole sulphide | 103876-98-8 | SYNONYMS: 2-[[(6-Methoxy-1H-benzimidazol-2-yl)thio]methyl]-3,5-dimethyl-4-pyridinol; Omeprazole Pyridone |
| RBPL-O0207 | Omeprazole Related Compound A | 88546-55-8 | SYNONYMS: omeprazole sulphone; 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfonyl]-1H-benzimidazole |
| RBPL-O0208 | omeprazole impurity E | 176219-04-8 | SYNONYMS: 6-Methoxy-2-[[(4-methoxy-3,5-dimethyl-1-oxido-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole; omeprazole-N-oxide |
| RBPL-O0209 | Omeprazole Related Compound B | 110374-16-8 | SYNONYMS: 4-Desmethoxy Omeprazole ;2-[(RS)-[(3,5-dimethylpyridin-2-yl)methyl]sulphinyl]-5-methoxy-1H-benzimidazole |
| OFLAXACIN | |||
| RBPL-O0301 | Oflaxacin impurity E | 82419-52-1 | SYNONYMS: Desmethyl Ofloxacin Hydrochloride; 9-Fluoro-2,3-dihydro-3-methyl-7-oxo-10-(1-piperazinyl)-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid; Oflaxacin related compound A |
| ONDENSETRON | |||
| RBPL-O0401 | Olanzapine impurity D | 99614-64-9 | SYNONYMS: 9-Methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one; 1,2,3,4-Tetrahydro-9-methyl-3-methylene-9H-carbazol-4-one; |
| OXYBUTYNIN | |||
| RBPL-O0501 | Oxybutynin related compound A | 4335-77-7 | SYNONYMS: Phenylcyclohexylglycolic Acid; α-Cyclohexylmandelic acid, 2-Cyclohexyl-2-hydroxy-2-phenylacetic acid; α-Cyclohexylmandelic acid |
| PIOGLITAZONE | |||
| RBPL-P0101 | Pioglitazone-N-oxide | 145350-09-0 | SYNONYMS: 5-[[4-[2-(5-Ethyl-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-thiazolidinedione N-Oxide |
| PARACETAMOL | |||
| RBPL-P0201 | Paracetamol impurity J | 539-03-7 | SYNONYMS: 4′-Chloroacetanilide; N-(4-Chlorophenyl)acetamide; N-(p-Chlorophenyl)acetamide; N-Acetyl-4-chloroaniline; N-Acetyl-p-chloroaniline; p-Chloroacetanilide; NSC 40563; NSC 444; Acetaminophen Related Compound J; |
| RBPL-P0202 | Paracetamol impurity F | 100-02-7 | SYNONYMS: 4-nitro phenol; p-Nitrophenol; 1-Hydroxy-4-nitrobenzene; 4-Hydroxy-1-nitrobenzene; 4-Hydroxynitrobenzene; NSC 1317; Niphen; p-Hydroxynitro benzene; |
| RBPL-P0203 | Paracetamol impurity K | 51-78-5 | SYNONYMS: 4-Amino phenol HCl; 4-Hydroxyaniline hydrochloride |
| PROPAFENONE | |||
| RBPL-P0301 | Propafenone impurity A | 3516-95-8 | SYNONYMS: 2'-Hydroxy-3-phenylpropiophenone; 1-(2-Hydroxy-phenyl)-3-phenyl-propan-1-one; |
| RBPL-P0306 | Propafenone impurity H | 27439-12-9 | SYNONYMS: (2R)-2-Phenyl-2,3-dihydro-4H-chromen-4-one; 4H-1-Benzopyran-4-one, 2,3-dihydro-2-phenyl-, (2R)- |
| RBPL-P0303 | Propafenone impurity F | 1329643-40-4 | SYNONYMS: 1,1’-[Hydroxypropane-1,3-diylbis(oxy-2,1-phenylene)]bis(3-phenylpropan-1-one); 1-(2-{2-hydroxy-3-[2-(3- phenylpropanoyl) phenoxy]propoxy}phenyl)-3- phenylpropan-1-one |
| RBPL-P0304 | Propafenone impurity G | 1346603-80-2 | SYNONYMS: Propafenone Dimer Impurity |
| RBPL-P0305 | Propafenone impurity H | 27439-12-9 | SYNONYMS: (2R)-2-Phenyl-2,3-dihydro-4H-chromen-4-one |
| RBPL-P0302 | Propafenone impurity C | 22525-95-7 | SYNONYMS: 2'-(2,3-Epoxypropoxy)-3-phenyl-propiophenone; 1-[2-(Oxiranylmethoxy)phenyl]-3-phenyl-1-propanone; 2-[[2-(3-Phenylpropanoyl)phenoxy]methyl]oxirane; |
| RBPL-P030 | Propafenone impurity E | 165279-79-8 | SYNONYMS: Depropylamino Chloro Propafenone; 1-[2-(3-Chloro-2-hydroxypropoxy)phenyl]-3-phenyl-1-propanone; |
| PROMETHAZINE | |||
| RBPL-P0401 | Promethazine impurity D | 7640-51-9 | SYNONYMS: Promethazine sulphoxide; N,N,α-Trimethyl-10H-phenothiazine-10-ethanamine 5-Oxide; N-[2-(Dimethylamino)propyl]phenothiazine S-Oxide; Promethazine 5-Oxide; Promethazine 5-Sulfoxide; Romergan Sulfoxide; |
| PACLITAXEL | |||
| RBPL-P0501 | Paclitaxel related compound B | 78454-17-8 | SYNONYMS: 7-Epi 10-Desacetyl Paclitaxel; 10-Deacetyl-7-epi-taxol; 10-Deacetyl-7-epitaxol; 10-Desacetyl-7-epipaclitaxel; 7-Epi-10-deacetyltaxol; 7-epi-10-Deacetyltaxol; Ormosin VI |
| PROPRANOLOL | |||
| RBPL-P0601 | Propranolol impurity A | 78454-17-8 | SYNONYMS: 7-Epi 10-Desacetyl Paclitaxel; 10-Deacetyl-7-epi-taxol; 10-Deacetyl-7-epitaxol; 10-Desacetyl-7-epipaclitaxel; 7-Epi-10-deacetyltaxol; 7-epi-10-Deacetyltaxol; Ormosin VI |
| RBPL-P0501 | Paclitaxel related compound B | 78454-17-8 | SYNONYMS: 7-Epi 10-Desacetyl Paclitaxel; 10-Deacetyl-7-epi-taxol; 10-Deacetyl-7-epitaxol; 10-Desacetyl-7-epipaclitaxel; 7-Epi-10-deacetyltaxol; 7-epi-10-Deacetyltaxol; Ormosin VI |
| PALONOSETRON | |||
| RBPL-P0701 | Dehydropalonosetron | NA | SYNONYMS: --- |
| QUETIAPINE | |||
| RBPL-Q0101 | Quetiapine impurity S | 329216-63-9 | SYNONYMS: Quetiapine-S-oxide; 2-[2-[4-(5-Oxidodibenzo[b,f][1,4]thiazepin-11-yl)-1-piperazinyl]ethoxy]ethanol; |
| RBPL-Q0102 | Quetiapine impurity F (II) | 848814-27-7 (FB) | SYNONYMS: 2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethanol; 1-[2-[(2-Aminophenyl)thio]benzoyl]-4-[2-(2-hydroxyethoxy)ethyl]-piperazine; [2-[(2-Aminophenyl)thio]phenyl][4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]-methanone |
| RBPL-Q0103 | Quetiapine impurity D | 945668-94-0 | SYNONYMS: Quetiapine Dimer; 11,11-(1,4-Piperazinediyl)bis-dibenzo[b,f][1,4]thiazepine; |
| RBPL-Q0104 | Quetiapine impurity G | C 3159-07-7 | SYNONYMS: Quetiapine Lactam; Quetiapine DBTO Metabolite; Quetiapine related compound G; Quetiapine related compound 01; Dibenzo[b,f][1,4]thiazepine-11-[10H]one; 4-(dibenzo[b,f][1,4]thiazepin-11-yl)-1-[2-(2-hydroxyethoxy)ethyl]piperazine-1-oxide |
| QUINAPRIL | |||
| RBPL-Q0201 | Quinapril Impurity C | 82768-85-2 | SYNONYMS: (3S)-2-[(2S)-2-[[(1S)-1-Carboxy-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic Acid; Quinaprilat; Quinapril related compound B |
| ROXITHROMYCIN | |||
| RBPL-R0102 | Roxithromycin impurity F | 118267-18-8 | SYNONYMS: N-Demethyl Roxithromycin; (9E)-9-[O-[(2-Methoxyethoxy)methyl]oxime]-N-demethyl Erythromycin; (E)-N-Demethylroxithromycin; RU 44981 |
| RABEPRAZOLE | |||
| RBPL-R0201 | Rabeprazole impurity B | 924663-37-6 | SYNONYMS: Rabeprazole sulphone N-oxide; 2-[[[4-(3-Methoxypropoxy)-3-methyl-1-oxido-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole; |
| RBPL-R0202 | Rabeprazole Impurity A | 108731-95-9 | SYNONYMS: Ramipril Diketopiperazine; (αS,3S,5aS,8aS,9aS)-Decahydro-3-methyl-1,4-dioxo-α-(2-phenylethyl)-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazine-2-acetic Acid Ethyl Ester; [3S-[2(R*),3α,5aβ,8aβ,9aβ]]-Decahydro-3-methyl-1,4-dioxo-α-(2-phenylethyl)-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazine-2-acetic Acid Ethyl Ester; Ramipril Related Compound D; |
| RAMIPRIL | |||
| RBPL-R0301 | Ramipril impurity D | 924663-37-6 | SYNONYMS: Ramipril Diketopiperazine; (αS,3S,5aS,8aS,9aS)-Decahydro-3-methyl-1,4-dioxo-α-(2-phenylethyl)-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazine-2-acetic Acid Ethyl Ester; [3S-[2(R*),3α,5aβ,8aβ,9aβ]]-Decahydro-3-methyl-1,4-dioxo-α-(2-phenylethyl)-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazine-2-acetic Acid Ethyl Ester; Ramipril Related Compound D; |
| RBPL-R0302 | Ramipril impurity B | 295328-72-2 | SYNONYMS: (2S,3aS,6aS)-Hexahydro-1-[(2S)-2-[[(1S)-1-[(1-methylethoxy)carbonyl]-3-phenylpropyl]amino]-1-oxopropyl]cyclopenta[b]pyrrole-2(2H)-carboxylic Acid; (2S,3aS,6aS)-Octahydro-1-[(2S)-2-[[(1S)-1-[(1-methylethoxy)carbonyl]-3- phenylpropyl]amino]-1-oxopropyl]cyclopenta[b]pyrrole-2-carboxylic Acid; Ramipril related compound B; Ramipril Isopropyl |
| RISPERIDONE | |||
| RBPL-R0401 | Risperidone impurity C | 144598-75-4 | SYNONYMS: 9-Hydroxy Risperidone; 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; Invega; Paliperidone; R 76477; RO 76477 |
| RBPL-R0402 | Risperidone-N-oxide | 832747-55-4 | SYNONYMS: 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-oxido-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one |
| RBPL-R0403 | Risperidone impurity E | 1346602-28-5 | SYNONYMS: 6-Methyl Risperidone; 3-[2-4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl-6,7,8,9-tetrahydro-2,6-dimethyl-4H-pyrido[1,2-a]pyrimidin-4-one; |
| RANITIDINE | |||
| RBPL-R0501 | Ranitidine impurity B | 66356-53-4 | SYNONYMS: 5-[[(2-Aminoethyl)thio]methyl]-N,N-dimethyl-2-furanmethanamine; 2-[[5-(Dimethylaminomethyl)-2-furanyl]methylthio]ethylamine; |
| RANITIDINE | |||
| RBPL-R0501 | Ranitidine impurity B | 66356-53-4 | SYNONYMS: 5-[[(2-Aminoethyl)thio]methyl]-N,N-dimethyl-2-furanmethanamine; 2-[[5-(Dimethylaminomethyl)-2-furanyl]methylthio]ethylamine; |
| RANITIDINE | |||
| RBPL-R0501 | Ranitidine impurity B | 66356-53-4 | SYNONYMS: 5-[[(2-Aminoethyl)thio]methyl]-N,N-dimethyl-2-furanmethanamine |
| RALOXIFENE | |||
| RBPL-R0801 | Raloxifene Related Compound C | 195454-31-0 | SYNONYMS: Raloxifene-N-oxide; [6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-oxido-1-piperidinyl)ethoxy]phenyl]methanone; |
| RANOLAZINE | |||
| RBPL-R0901 | Ranolazine-N-oxide | NA | SYNONYMS: --- |
| SILDENAFIL | |||
| RBPL-S0101 | N-desmethyl Sildenafil | 139755-82-1 | SYNONYMS: 5-[2-Ethoxy-5-(1-piperazinylsulfonyl)phenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one; UK 103320 |
| RBPL-S0102 | Sildenafil impurity B | 1094598-75-0 | SYNONYMS: Sildenafil-N-oxide; 5-[2-Ethoxy-5-[(4-methyl-4-oxido-1-piperazinyl)sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one; |
| TELMISATRAN | |||
| RBPL-T0101 | Telmisatran impurity F | 915124-86-6 | SYNONYMS: Telmisartan Amide; 4-[(1,4-Dimethyl-2-propyl[2,6-bi-1H-benzimidazol]-1-yl)methyl][1,1-biphenyl]-2-carboxamide; |
| RBPL-T0102 | Telmisatran related compound A | 152628-02-9 | SYNONYMS: 2-n-Propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazole |
| TRAMADOL | |||
| RBPL-T0201 | Tramadol-N-oxide | 147441-56-3 | SYNONYMS: (1R,2R)-rel-2-[(Dimethyloxidoamino)methyl]-1-(3-methoxyphenyl)-cyclohexanol; RWJ 38705; |
| RBPL-T0202 | Tramadol impurity A | 2914-77-2; 152538-36-8 (Freebase); 73806-49-2 | SYNONYMS: (1RS,2SR)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol; (1RS,2SR)-2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol Hydrochloride; Tramadol related compound A |
| RBPL-T0203 | Tramadol impurity D | NA | SYNONYMS: --- |
| THIOCHOLCHICOSIDE | |||
| RBPL-T0301 | Thiocolchicine metabolite | 87424-25-7 | SYNONYMS: N-[(7S)-5,6,7,9-Tetrahydro-3-hydroxy-1,2-dimethoxy-10-(methylthio)-9-oxobenzo[a]heptalen-7-yl]acetamide; 2-Demethylthio-colchicine; 3-Desmethylthiocolchicine; NSC 361792; |
| TROSPIUM | |||
| RBPL-T0401 | Trospium chloride related compound A | 76-93-7 | SYNONYMS: Benzilic acid; α-Hydroxy-α-phenylbenzeneacetic Acid; 2,2-Diphenyl-2-hydroxyacetic Acid; 2,2-Diphenyl-2-hydroxyethanoic Acid; 2,2-Diphenylglycolic Acid; 2-Hydroxy-2,2-diphenylacetic Acid; Diphenylglycolic Acid; Diphenylhydroxyacetic Acid; Hydroxydiphenylacetic Acid; NSC 2830; α,α-Diphenyl-α-hydroxyacetic Acid; α,α-Diphenylglycolic Acid; α-Hydroxy-2,2-diphenylacetic Acid; α-Hydroxy-α-phenylbenzeneacetic Acid; α-Hydroxydiphenylacetic Acid; Trospium Chloride Related Compound A; |
| RBPL-T0402 | Trospium impurity D | 467-32-3 | SYNONYMS: Benzilide; 3,3,6,6-Tetraphenyl-1,4-dioxane-2,5-dione; NSC 403081; NSC 677243 |
| TIMOLOL | |||
| RBPL-T0601 | Timolol impurity D | NA | SYNONYMS: 4-Morpholino-1,2,5-thiadiazol-3-ol; |
| RBPL-T0602 | Timolol impurity B | 158636-96-5 | SYNONYMS: 3-(tert-butylamino)-2-(4-morpholino-1,2,3-thiadiazol-3-yloxy)propan-1-ol; Isotimolol (S) |
| TOLTERIDONE | |||
| RBPL-T0701 | Tolteridone lactone | 40546-94-9 | SYNONYMS: rac-6-Methyl-4-phenylchroman-2-one; 6-Methyl-4-phenyl-3,4-dihydro-1-benzopyran-2-one; 6-Methyl-4-phenylchroman-2-one; 6-Methyl-4-phenyl-3,4-dihydrocoumarin |
| RBPL-T0702 | Tolteridone impurity E | 480432-14-2 | SYNONYMS: 4-Methyl-2-[3-[(1-methylethyl) amino]-1-phenylpropyl]phenol; N-Isopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenyl propylamine; rac Desisopropyl Tolterodine |
| VERAPAMIL | |||
| RBPL-V0101 | Verapamil impurity I Norvarapamil HCl | 67812-42-4 | SYNONYMS: α-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]amino]propyl]-3,4-dimethoxy-α-(1-methylethyl)- benzeneacetonitrile |
| Venlafaxine | |||
| RBPL-V0201 | Desvenlafaxine | 93413-62-8; 386750-22-7-for succinate salt | SYNONYMS: 4-[2-(Dimethylamino)-1-(1-hydroxycyclo-hexyl)ethyl]phenol; DVS 233; Desvenlafaxine; O-Desmethylvenlafaxine; Pristiq; WY 45233; |
| ZIDOVUDINE | |||
| RBPL-Z0101 | Zidovudine related compound B | 25526-94-7 | SYNONYMS: 3-Chloro-3-deoxythymidine |
| ZIPRASIDONE | |||
| RBPL-Z0201 | Ziprasidone related compound B | 1159977-56-6 | SYNONYMS: 3-Oxo Ziprasidone; (5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindoline-2,3-dione); 5-[2-[4-(1,2-Benzisothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1H-indole-2,3-dione |
| RBPL-Z0202 | Ziprasidone impurity E | 1159977-04-4 | SYNONYMS: 3-(Benzo[d]isothiazol-3-yl)-5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one; Ziprasidone Related Compound D; 3-(1,2-Benzisothiazolyl) Ziprasidone; Ziprasidone related compound D |
